Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr 28;8(2):205. doi: 10.3390/vaccines8020205

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Body temperature and clinical course. (A,F) Five goats each were either left unvaccinated, (B,G) double inoculated with rNDV, (C,H) single vaccinated with PPRV Nigeria 75/1, (D,I) single vaccinated with rNDV_H_Kur, or (E,J) double vaccinated with rNDV_H_Kur. All goats were infected with PPRV Kurdistan/11 three weeks after immunization. (A–E) Rectal body temperatures were monitored daily, beginning one day prior to the first immunization. (F–J) Clinical signs were assessed daily for three weeks after challenge infection and the clinical scores calculated as described in Section 2.

Body temperature and clinical course. (A,F) Five goats each were either left unvaccinated, (B,G) double inoculated with rNDV, (C,H) single vaccinated with PPRV Nigeria 75/1, (D,I) single vaccinated with rNDV_H_Kur, or (E,J) double vaccinated with rNDV_H_Kur. All goats were infected with PPRV Kurdistan/11 three weeks after immunization. (A–E) Rectal body temperatures were monitored daily, beginning one day prior to the first immunization. (F–J) Clinical signs were assessed daily for three weeks after challenge infection and the clinical scores calculated as described in Section 2.